263 related articles for article (PubMed ID: 31653462)
21. Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study.
Tanaka ST; Yerkes EB; Routh JC; Tu DD; Austin JC; Wiener JS; Vasquez E; Joseph DB; Ahn JJ; Wallis MC; Williams T; Rose C; Baum MA; Cheng EY
J Pediatr Urol; 2021 Oct; 17(5):726-732. PubMed ID: 34011486
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
Marte A; Vessella A; Cautiero P; Romano M; Borrelli M; Noviello C; Del Gado R; Parmeggiani P
Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
[TBL] [Abstract][Full Text] [Related]
23. Comparison of risk of anticholinergic utilization for treatment of neurogenic bladder between in utero or postnatal myelomeningocele repair.
Zaccaria L; Daugherty M; Grant C; Strine AC; Reddy PP; DeFoor WR; Minevich E; Lim FY; VanderBrink BA
J Pediatr Urol; 2021 Aug; 17(4):525.e1-525.e7. PubMed ID: 34074608
[TBL] [Abstract][Full Text] [Related]
24. How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
Lee AS; Viseshsindh W; Long CJ; Frazier JR; Moran MH; Zderic SA; Weiss DA
J Pediatr Urol; 2020 Apr; 16(2):168.e1-168.e6. PubMed ID: 32115375
[TBL] [Abstract][Full Text] [Related]
25. Neuropathic Bladder and Augmentation Cystoplasty.
Roth JD; Cain MP
Urol Clin North Am; 2018 Nov; 45(4):571-585. PubMed ID: 30316312
[TBL] [Abstract][Full Text] [Related]
26. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
[TBL] [Abstract][Full Text] [Related]
27. Risk determination for upper urinary tract damage in children with neuropathic bladder.
Ekberlİ G; Taner S
J Paediatr Child Health; 2023 Jul; 59(7):863-870. PubMed ID: 36999336
[TBL] [Abstract][Full Text] [Related]
28. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup.
Hopps CV; Kropp KA
J Urol; 2003 Jan; 169(1):305-8. PubMed ID: 12478177
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of videourodynamic study in the decision-making of surgical intervention and bladder management for neurogenic lower urinary tract dysfunction among patients with myelomeningocele.
Yu WR; Kuo HC
Int Urol Nephrol; 2022 Aug; 54(8):1815-1824. PubMed ID: 35608803
[TBL] [Abstract][Full Text] [Related]
30. Bladder perforation in augmentation cystoplasty during urodynamic investigation: a case report and review of the literature.
Ehdaie B; Mason MD; Gray M; Peters CA; Corbett ST
J Pediatr Urol; 2013 Apr; 9(2):e102-6. PubMed ID: 23238439
[TBL] [Abstract][Full Text] [Related]
31. Long term results of augmentation cystoplasty and urinary diversion in multiple sclerosis.
Kalkan S; Jaffe WI; Simma-Chiang V; Li ESW; Blaivas JG
Can J Urol; 2019 Jun; 26(3):9774-9780. PubMed ID: 31180308
[TBL] [Abstract][Full Text] [Related]
32. Predictors of upper tract damage in pediatric neurogenic bladder.
Prakash R; Puri A; Anand R; Jain AK; Lal B; Garg V
J Pediatr Urol; 2017 Oct; 13(5):503.e1-503.e7. PubMed ID: 28385450
[TBL] [Abstract][Full Text] [Related]
33. Ureteral reimplantation during augmentation cystoplasty is not needed for vesicoureteral reflux in patients with neurogenic bladder: a long-term retrospective study.
Chiba H; Kitta T; Higuchi M; Kusakabe N; Kon M; Nakamura M; Shinohara N
BMC Urol; 2022 Mar; 22(1):48. PubMed ID: 35351067
[TBL] [Abstract][Full Text] [Related]
34. Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?
Tarcan T; Onol FF; Ilker Y; Simsek F; Ozek M
J Urol; 2006 Oct; 176(4 Pt 1):1601-6; discussion 1606. PubMed ID: 16952698
[TBL] [Abstract][Full Text] [Related]
35. Upper tract changes in patients with neurogenic bladder and sustained pressures >40 cm following bladder neck surgery without augmentation.
Snodgrass W; Villaneuva C; Jacobs M; Gargollo P
J Pediatr Urol; 2014 Aug; 10(4):744-8. PubMed ID: 24566376
[TBL] [Abstract][Full Text] [Related]
36. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
[TBL] [Abstract][Full Text] [Related]
37. Initial urologic management of myelomeningocele.
Snodgrass WT; Adams R
Urol Clin North Am; 2004 Aug; 31(3):427-34, viii. PubMed ID: 15313052
[TBL] [Abstract][Full Text] [Related]
38. Implications of Bacteriuria in Myelomeningocele Patients at Time of Urodynamic Testing.
Preece J; Haynes A; Gupta S; Becknell B; Ching C
Top Spinal Cord Inj Rehabil; 2019; 25(3):241-247. PubMed ID: 31548791
[No Abstract] [Full Text] [Related]
39. Onabotulinumtoxin A for treating overactive/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningocele.
Marte A
Toxins (Basel); 2012 Dec; 5(1):16-24. PubMed ID: 23274271
[TBL] [Abstract][Full Text] [Related]
40. A simple screening tool for an unfavorable bladder in children with myelomeningocele: Is the height to width ratio of the cystogram useful to predict high-pressure bladder?
Kumano Y; Hayashi C; Gohbara A; Yamazaki Y
J Pediatr Urol; 2020 Dec; 16(6):839.e1-839.e5. PubMed ID: 33023850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
